Table 1.
Number and percentage of isolates from each lineage that tested resistant to each antimicrobial
| |
|
Number and percentage (%) of tested isolates resistant to antimicrobial substance |
||||
|---|---|---|---|---|---|---|
| LINEAGE (n) | Dominant CC | Tetracycline | Quinolones3 | Erythromycin | Chloramphenicol | Aminoglycosides |
| 1 (209) |
828 |
76 (36.4) |
51 (24.40) |
29 (13.88) |
7 (3.35) |
4 (1.91) |
| 2 (187) |
45 |
102 (54.55) |
22 (11.76) |
3 (1.60) |
1 (0.53) |
1 (0.53) |
| 3 (131) |
257 |
40 (30.53) |
28 (21.37) |
1 (0.76) |
2 (1.53) |
2 (1.53) |
| 4 (44) |
433 |
30 (68.18) |
9 (20.45) |
2 (4.55) |
3 (6.82) |
3 (6.82) |
| 5 (21) |
661 |
19 (90.48) |
5 (23.81) |
1 (4.76) |
1 (4.76) |
2 (9.52) |
| 6 (16) |
354 |
7 (43.75) |
6 (37.50) |
0 |
1 (6.25) |
0 |
| 7 (7) |
49 |
4 (57.14) |
3 (42.86) |
1 (14.29) |
1 (14.29) |
0 |
| 8 (5) |
21 |
1 (20.00) |
0 |
0 |
0 |
0 |
| 9 (35) |
443 |
32 (91.43) |
15 (42.86) |
3 (8.57) |
2 (8.57) |
1 (2.86) |
| 10 (5) |
574 |
3 (60.00) |
1 (20.00) |
0 |
0 |
0 |
| 11 (8) |
52 |
0 |
1 (12.50) |
0 |
0 |
0 |
| 12 (3) |
21 |
0 |
0 |
0 |
0 |
0 |
| 13 (11) |
42 |
2 (18.18) |
2 (18.18) |
0 |
0 |
0 |
| 14 (12) |
21 |
4 (33.33) |
3 (25.00) |
0 |
2 (16.67) |
0 |
| 15 (21) |
21 |
8 (38.10) |
3 (14.29) |
0 |
0 |
0 |
| 16 (3) |
206 |
3 (100.00) |
0 |
0 |
0 |
0 |
| 17 (4) |
508 |
1 (25.00) |
0 |
1 (25.00) |
1 (25.00) |
0 |
| 18 (10) |
353 |
2 (20.00) |
1 (10.00) |
0 |
0 |
0 |
| 19 (10) |
607 |
1 (10.00) |
0 |
0 |
0 |
0 |
| 20 (7) |
21 |
2 (28.57) |
6 (85.71) |
0 |
3 (42.86) |
0 |
| 21 (4) |
22 |
0 |
0 |
0 |
0 |
0 |
| 22 (7) |
61 |
0 |
0 |
0 |
0 |
0 |
| 23 (10) |
|
6 (60.00) |
9 (90.00) |
0 |
0 |
0 |
| 24 (3) |
|
3 (100.00) |
1 (33.33) |
0 |
0 |
0 |
| 25 (2) | 0 | 1 (50.00) | 0 | 0 | 0 | |
1 Lineages are defined as clusters of related genotypes based upon the ClonalFrame genealogy.
2 The clonal complex to which most of the STs belong.
3 Naladixic acid and ciprofloxacin.